TWiV 1165: What doesn’t kill us primes our macrophages

November 10, 2024

TWiV notes the passing of virologist Diane Griffin, first H5N1 influenza virus in US pigs, Innate immune control of influenza virus interspecies adaptation via IFITM3, and antiviral trained innate immunity in alveolar macrophages after SARS-CoV-2 infection reduces secondary influenza A virus disease.

Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker

Click arrow to play
Download TWiV 1165 (63 MB .mp3, 105 min)
Subscribe (free): Apple PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Weekly Picks 1:21:01

AngelaSee a giant ‘ghost particle’ detector and more — October’s best science images
BrianneOctober 27 APoD: Bat nebula
DicksonNikon Small World Contest 2024 winners
KathyAAAS 150th anniversary video, celebrating scientists and Pew’s 2024 annual Trust in Science survey findings
Rich – Cats Basically Are a Liquid After All, Study Confirms
Alan – HHMI’s Beautiful Biology site
VincentEcoHealth Alliance Fights Back

Listener Picks

HunterDon’t stop me now: Queen’s Brian May on saving badgers — and the scientific method
AnneReasons to be cheerful

Intro music is by Ronald Jenkees

Send your virology questions and comments to twiv@microbe.tv

Content in this podcast should not be construed as medical advice.

The post TWiV 1165: What doesn’t kill us primes our macrophages first appeared on This Week in Virology.

Leave a Reply

Your email address will not be published. Required fields are marked *

0 comments on “TWiV 1165: What doesn’t kill us primes our macrophages

  1. Connor Bamford May 7, 2012

    With this paper and the Dutch one we now know that H5 influenza viruses can become transmissible between mammals in the lab but can we say how easy it would be to achieve this in the wild? From what I can tell the two groups had to put these viruses through intense mutation/selection. But maybe this is really nothing in comparison to the mutation rate of these RNA viruses in birds.

    •  it didn’t happen so far. (except N158D)
      And there is not much reason to do so in birds.
      Maybe after xxyy passages in humans …
      And then they added the reassortment, they
      didn’t test it without the reassortment
      (or at least they don’t write about it)

      4 mutations is still quite a lot. Compare with the one mutation
      that is needed for Tamiflu-resistance. It happens maybe in 20%
      of treated cases. 20%^4 = 1 out of 625 , if we could construct a chain
      such  that each one added mutation gives an advantage

  2. niman May 13, 2012

    The latest podcast really failed to address the similarities between all three H5N1 transmission studies, and the fact that the Rubin Donis (CDC) paper had already been published in full (in Virology).  Thus, one recipe was already public, and it was well known that Fouchier started with three changes (all of which were in the Virology published paper) and pasaage in ferrets led to the selection of the other two.  Thus, the claim that publication of an unredacted paper would delay nefarious applications really had no basis in fact (passage and selection in ferrets is not a new concept or technique).  The Kawaoaka paper (which also used selection in ferrets) is now public, and it is relarkably similar to the Domis and Fouchier papers, so once again the votes of the 6 NSABB members against publication of an unredacted Fouchier paper has no really science (or facts) to justify such a vote.

    Moreover, claims that none of the changes other than N158D were in circulation after 2003 is false.  N224K has been found in H5N1 in Egypt and Vietnam. while T318T has been found  in H5N1 in China. (and the aboltion of the position 158 glycosylation has been found in all but one, out of more than 100, clade 2.2 human cases).

    http://www.recombinomics.com/News/04171202/H5N1_Transmission_Egypt.html